FZD10 and colorectal carcinoma: Preliminarily, quantitative and qualitative evaluation of the cellular FZD10 expression in CaCo-2 and CoLo-205 cells was made by immunoblotting and immunofluorescence, respectively, to validate the use of the FZD10 engineered LPs for targeted treatment of CRC (see Supplementary Materials).